Chromosome Abnormalities in Patients Treated with Chlorpromazine, Perphenazine, and Lysergide
Authors:
- J. NielsenJNJ. Nielsen
- U. FriedrichUFU. Friedrich
- T. TsuboiTTT. Tsuboi
Abstract
In a chromosome study on leucocyte cultures made in 13 patients treated with chlorpromazine, 15 treated with perphenazine, and nine treated with lysergide, a significantly higher frequency of gaps, breaks, and hypodiploid cells in the patients treated with perphenazine and lysergide occurred compared with the 41 controls studied. It is concluded that if some drugs can induce major chromosome abnormalities, and less toxic alternatives are available, the latter should be used in preference.Keywords
This publication has 11 references indexed in Scilit:
- Meiotic Chromosome Damage induced by LSD-25Nature, 1968
- Lysergide and chromosome abnormalities.BMJ, 1968
- Chromosome Abnormalities and Psychotropic DrugsNature, 1968
- Chromosomal damage in LDsersJAMA, 1968
- In Vivo and in Vitro Chromosomal Damage Induced by LSD-25New England Journal of Medicine, 1967
- Congenital Malformations Induced by Mescaline, Lysergic Acid Diethylamide, and Bromolysergic Acid in the HamsterScience, 1967
- Lysergic Acid Diethylamide: Effect on EmbryosScience, 1967
- LSD: Injection Early in Pregnancy Produces Abnormalities in Offspring of RatsScience, 1967
- Chromosomal Abnormalities in Leukocytes from LSD-25 UsersScience, 1967
- Chromosomal Damage in Human Leukocytes Induced by Lysergic Acid DiethylamideScience, 1967